| Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey--1974. |
| Exelby PR, Filler RM, Grosfeld JL. |
| J Pediatr Surg.1975;10:329-337 |
| |
| Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. |
| Koufos A, Hansen M, Copeland N, Jenkins N, Lampkin B, Cavenee W. |
| Nature.1985;316:330-334 |
| |
| The international incidence of childhood cancer. |
| Parkin DM, Stiller CA, Draper GJ, Bieber CA. |
| Int J Cancer.1988;42:511-520 |
| |
| Cytogenetic and molecular studies on six sporadic hepatoblastomas. |
| Kiechle-Schwarz M, Scherer G, Kovacs G. |
| Cancer Genet Cytogenet.1989;41:286 |
| |
| Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. |
| Koufos A, Grundy P, Morgan K, Aleck K, Hadro T, Lampkin B, Kalbakji A, Cavenee W. |
| Am J Hum Genet.1989;44:711-719 |
| |
| Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. |
| Ping A, Reeve A, Law D, Young M, Boehnke M, Feinberg A. |
| Am J Hum Genet.1989;44:720-723 |
| |
| Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. |
| DA, Cherlow J, . |
| J Clin Oncol.1991;9:2167-2176 |
| |
| Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver. |
| Byrne J, Simms L, Little M, Algar E, Smith P. |
| Genes Chromosom Cancer.1993;8:104-111 |
| |
| Mutation at codon 249 of the p53 gene in a human hepatoblastoma. |
| Kar S, Jaffe R, Carr B. |
| Hepatology.1993;18:566-569 |
| |
| Chemotherapy effects on hepatoblastoma. A histological study. |
| Saxena R, Leake JL, Shafford EA, Davenport M, Mowat AP, Pritchard J, Mieli-Vergani G, Howard ER, Spitz L, Malone M, . |
| Am J Surg Pathol.1993;17:1266-1271 |
| |
| Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. |
| Albrecht S, von Schweinitz D, Waha A, Kraus J, von Deissling A, Pietsch T. |
| Cancer Res.1994;54:5041-5044 |
| |
| Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. |
| Montagna M, Menin C, Chieco-Bianchi L, D'Andrea E. |
| J Cancer Res Clin Oncol.1994;120:732-736 |
| |
| Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. |
| Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekstrom T. |
| Oncogene.1995;11:221-229 |
| |
| A mutational hotspot in the p53 gene is associated with hepatoblastomas. |
| Oda H, Nakatsuru Y, Imai Y, Sugimura H, Ishikawa T. |
| Int J Cancer.1995;60:786-790 |
| |
| Loss of imprinting in hepatoblastoma. |
| Rainier S, Dobry C, Feinberg A. |
| Cancer Res.1995;55:1836-1838 |
| |
| Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89. |
| von Schweinitz D, Hecker H, Harms D, Bode U, Weinel P, Burger D, Erttmann R, Mildenberger H. |
| J Pediatr Surg.1995;30:845-852 |
| |
| Loss of heterozygosity on chromosome 1 in human hepatoblastoma. |
| Kraus J, Albrecht S, Wiestler O, von Schweinitz D, Pietsch T. |
| Int J Cancer.1996;67:467-471 |
| |
| Somatic mutations of the APC gene in sporadic hepatoblastomas. |
| Oda H, Imai Y, Nakatsuru Y, Hata J, Ishikawa T. |
| Cancer Res.1996;56:3320-3323 |
| |
| Significance of extra copies of chromosome 20 and the long arm of chromosome 2 in hepatoblastoma. |
| Swarts S, Wisecarver J, Bridge J. |
| Cancer Genet Cytogenet.1996;91:65-67 |
| |
| The first recurring chromosome translocation in hepatoblastoma: der(4)t(1;4)(q12;q34). |
| Schneider N, Cooley L, Finegold M, Douglass E, Tomlinson G. |
| Genes Chromosom Cancer.1997;19:291-294 |
| |
| Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group. |
| Van Tornout JM, Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA. |
| J Clin Oncol.1997;15:1190-1197 |
| |
| Parkin DM, Kramarova E, Draper GJ. |
| International incidence of childhood cancer, vol. II. IARC Scientific publications. 1998. |
| |
| Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. |
| Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T. |
| Cancer Res.1999;59:269-273 |
| |
| Comparative genomic hybridization analysis of hepatoblastomas: additional evidence for a genetic link with Wilms tumor and rhabdomyosarcoma. |
| Steenman M, Tomlinson G, Westerveld A, Mannens M. |
| Cytogenet Cell Genet.1999;86:157-161 |
| |
| Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. |
| Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, Dicks-Mireaux C, Phillips A, Vos A, Plaschkes J. |
| Eur J Cancer.2000;36:1418-1425 |
| |
| Childhood cancers: hepatoblastoma. |
| Herzog CE, Andrassy RJ, Eftekhari F. |
| Oncologist.2000;5:445-453 |
| |
| Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. |
| Jeng YM, Wu MZ, Mao TL, Chang MH, Hsu HC. |
| Cancer Lett.2000;152:45-51 |
| |
| Cytogenetic characterization of childhood hepatoblastoma. |
| Ma SK, Cheung AN, Choy C, Chan GC, Ha SY, Ching LM, Wan TS, Chan LC. |
| Cancer Genet Cytogenet.2000;119:32-36 |
| |
| Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. |
| Weber RG, Pietsch T, von Schweinitz D, Lichter P. |
| Am J Pathol.2000;157:571-578 |
| |
| Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. |
| Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA. |
| Oncogene.2000;19:498-504 |
| |
| Trisomy 1q, 2, and 20 in a case of hepatoblastoma: possible significance of 2q35-q37 and 1q12-q21 rearrangements. |
| Yeh YA, Rao PH, Cigna CT, Middlesworth W, Lefkowitch JH, Murty VV. |
| Cancer Genet Cytogenet.2000;123:140-143 |
| |